Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis-Reference-Cited by-同舟云学术

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Published:2000-06-16 Issue:1 Volume:46 Page:19-26
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Tetef Merry L.,Margolin Kim A.,Doroshow James H.,Akman Steven,Leong Lucille A.,Morgan Jr. Robert J.,Raschko James W.,Slatkin Neil,Somlo George,Longmate Jeffrey A.,Carroll Mary I.,Newman Edward M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800000118.pdf

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Leptomeningeal Metastases from Breast Cancer: A Literature Review;Journal of Medical Clinical Case Reports;2024-12-15

2. Regulation of folate transport at the mouse arachnoid barrier;Fluids and Barriers of the CNS;2024-08-27

3. Improving measured health-related quality of life with outpatient high-dose methotrexate regimen among oncology patients with intracranial metastases: A systematic assessment;Archives of Nursing Practice and Care;2023-12-30

4. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?;Expert Review of Neurotherapeutics;2023-12-25

5. Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management;Gynecologic Oncology;2023-05